Business & Economics
Early Intervention
100%
Hypertension
82%
Therapy
52%
Economics
33%
Hospitalization
32%
Drugs
21%
Cost-benefit
14%
Healthcare
13%
Efficacy
12%
Economic Impact
11%
Burden
11%
Costs
10%
Prospective Study
9%
Pharmacoeconomics
9%
Health Care Utilization
9%
Morbidity
8%
Medication
7%
Economic Modelling
7%
Economic Data
7%
World Health Organization
7%
Data Base
6%
Pharmaceuticals
5%
Modeling
3%
Social Sciences
clinical outcomes
89%
hypertension
82%
hospitalization
32%
management
31%
economics
28%
costs
24%
health care
15%
economic impact
15%
drug
15%
Health Care Utilization
10%
inpatient care
10%
drug therapy
10%
morbidity
7%
WHO
6%
pharmaceutical
6%
medication
6%
evidence
6%
economy
4%
literature
3%
Medicine & Life Sciences
Pulmonary Arterial Hypertension
78%
Economics
51%
Hospitalization
24%
Drug Costs
20%
Delivery of Health Care
15%
Pharmaceutical Economics
10%
Therapeutics
10%
Costs and Cost Analysis
10%
Patient Acceptance of Health Care
9%
Pharmacy
8%
Secondary Prevention
8%
MEDLINE
7%
Pharmaceutical Preparations
6%
Inpatients
6%
PubMed
6%
Prospective Studies
5%
Databases
4%
Morbidity
4%
Drug Therapy
4%